Thomas Shaw Buys 32,935 Shares of Retractable Technologies (NYSE:RVP) Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas Shaw bought 32,935 shares of the stock in a transaction on Monday, August 18th. The stock was purchased at an average cost of $0.80 per share, with a total value of $26,348.00. Following the purchase, the chief executive officer directly owned 15,636,283 shares of the company’s stock, valued at approximately $12,509,026.40. This represents a 0.21% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link.

Retractable Technologies Stock Down 1.6%

Shares of RVP stock opened at $0.8348 on Friday. The firm has a fifty day moving average of $0.70 and a 200-day moving average of $0.72. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. Retractable Technologies, Inc. has a 12-month low of $0.5649 and a 12-month high of $0.99. The company has a market capitalization of $24.99 million, a price-to-earnings ratio of -1.55 and a beta of 1.15.

Analyst Ratings Changes

Separately, Wall Street Zen assumed coverage on shares of Retractable Technologies in a research report on Thursday, May 22nd. They set a “hold” rating for the company.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Retractable Technologies stock. Renaissance Technologies LLC boosted its holdings in Retractable Technologies, Inc. (NYSE:RVP) by 9.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 361,253 shares of the company’s stock after purchasing an additional 31,140 shares during the period. Renaissance Technologies LLC owned about 1.21% of Retractable Technologies worth $249,000 as of its most recent filing with the Securities and Exchange Commission. 7.58% of the stock is owned by hedge funds and other institutional investors.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.